Aconitase Causes Iron Toxicity in Drosophila pink1 Mutants

PLoS Genetics

Volumn 9, Issue 4, 2013, Pages

  Esposito, Giovanni ^a,b   Vos, Melissa ^a,b   Vilain, Sven ^a,b   Swerts, Jef ^a,b   de Sousa Valadas, Jorge ^a,b   van Meensel, Stefanie ^a,b   Schaap, Onno ^a,b   Verstreken, Patrik ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACONITATE HYDRATASE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; IRON; MITOCHONDRIAL ENZYME; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE INDUCED KINASE1; SUPEROXIDE; UNCLASSIFIED DRUG; DROSOPHILA PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL SWELLING; CONTROLLED STUDY; DOWNSTREAM PROCESSING; DROSOPHILA; ENZYME LOCALIZATION; GENE; GENE INACTIVATION; GENE REPRESSION; GENETIC ANALYSIS; IRON KINETICS; IRON OVERLOAD; IRON RELEASE; MALE; MITOCHONDRION; MOLECULAR MECHANICS; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PINK1 GENE; PROTEIN EXPRESSION; ANIMAL; GENETICS; HUMAN; METABOLISM;

ACONITATE HYDRATASE; ANIMALS; DROSOPHILA; DROSOPHILA PROTEINS; HUMANS; IRON; MITOCHONDRIA; PARKINSON DISEASE;

EID: 84876841576     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1003478     Document Type: Article

References (65)

1. Dawson TM, Dawson VL, (2003) Molecular pathways of neurodegeneration in Parkinson's disease. Science 302: 819-822.
2. Thomas B, Beal MF, (2007) Parkinson's disease. Hum Mol Genet 16 Spec No. 2: R183-194.
3. Horowitz MP, Greenamyre JT, (2010) Mitochondrial iron metabolism and its role in neurodegeneration. J Alzheimers Dis 20 Suppl 2: S551-568.
4. Sofic E, Paulus W, Jellinger K, Riederer P, Youdim MB, (1991) Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J Neurochem 56: 978-982.
5. Lestienne P, Nelson J, Riederer P, Jellinger K, Reichmann H, (1990) Normal mitochondrial genome in brain from patients with Parkinson's disease and complex I defect. J Neurochem 55: 1810-1812.
6. Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB, et al. (1989) Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1: 1269.
7. Dawson TM, Ko HS, Dawson VL, (2010) Genetic animal models of Parkinson's disease. Neuron 66: 646-661.
8. Jones R, (2010) The roles of PINK1 and Parkin in Parkinson's disease. PLoS Biol 8: e1000299 doi:10.1371/journal.pbio.1000299.
9. Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, et al. (2006) Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441: 1162-1166.
10. Park J, Lee SB, Lee S, Kim Y, Song S, et al. (2006) Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441: 1157-1161.
11. Jin SM, Youle RJ, (2012) PINK1- and Parkin-mediated mitophagy at a glance. J Cell Sci 125: 795-799.
12. Deng H, Dodson MW, Huang H, Guo M, (2008) The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proc Natl Acad Sci U S A 105: 14503-14508.
13. Poole AC, Thomas RE, Andrews LA, McBride HM, Whitworth AJ, et al. (2008) The PINK1/Parkin pathway regulates mitochondrial morphology. Proc Natl Acad Sci U S A 105: 1638-1643.
14. Yang Y, Ouyang Y, Yang L, Beal MF, McQuibban A, et al. (2008) Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery. Proc Natl Acad Sci U S A 105: 7070-7075.
15. Narendra DP, Jin SM, Tanaka A, Suen DF, Gautier CA, et al. (2010) PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol 8: e1000298 doi:10.1371/journal.pbio.1000298.
16. Yang Y, Gehrke S, Imai Y, Huang Z, Ouyang Y, et al. (2006) Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc Natl Acad Sci U S A 103: 10793-10798.
17. Gautier CA, Kitada T, Shen J, (2008) Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. Proc Natl Acad Sci U S A 105: 11364-11369.
18. Morais VA, Verstreken P, Roethig A, Smet J, Snellinx A, et al. (2009) Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function. EMBO Mol Med 1: 99-111.
19. Vilain S, Esposito G, Haddad D, Schaap O, Dobreva MP, et al. (2012) The yeast complex I equivalent NADH dehydrogenase rescues pink1 mutants. PLoS Genet 8: e1002456 doi:10.1371/journal.pgen.1002456.
20. Liu W, Acin-Perez R, Geghman KD, Manfredi G, Lu B, et al. (2011) Pink1 regulates the oxidative phosphorylation machinery via mitochondrial fission. Proc Natl Acad Sci U S A 108: 12920-12924.
21. Vos M, Esposito G, Edirisinghe JN, Vilain S, Haddad DM, et al. (2012) Vitamin K2 is a mitochondrial electron carrier that rescues pink1 deficiency. Science 336: 1306-1310.
22. Beinert H, Kennedy MC, (1993) Aconitase, a two-faced protein: enzyme and iron regulatory factor. FASEB J 7: 1442-1449.
23. Lauble H, Kennedy MC, Beinert H, Stout CD, (1992) Crystal structures of aconitase with isocitrate and nitroisocitrate bound. Biochemistry 31: 2735-2748.
24. Hiesinger PR, Fayyazuddin A, Mehta SQ, Rosenmund T, Schulze KL, et al. (2005) The v-ATPase V0 subunit a1 is required for a late step in synaptic vesicle exocytosis in Drosophila. Cell 121: 607-620.
25. Uytterhoeven V, Kuenen S, Kasprowicz J, Miskiewicz K, Verstreken P, (2011) Loss of skywalker reveals synaptic endosomes as sorting stations for synaptic vesicle proteins. Cell 145: 117-132.
26. Verstreken P, Ohyama T, Haueter C, Habets RL, Lin YQ, et al. (2009) Tweek, an evolutionarily conserved protein, is required for synaptic vesicle recycling. Neuron 63: 203-215.
27. Flint DH, Tuminello JF, Emptage MH, (1993) The inactivation of Fe-S cluster containing hydro-lyases by superoxide. J Biol Chem 268: 22369-22376.
28. Gardner PR, Fridovich I, (1991) Superoxide sensitivity of the Escherichia coli 6-phosphogluconate dehydratase. J Biol Chem 266: 1478-1483.
29. Gardner PR, Fridovich I, (1991) Superoxide sensitivity of the Escherichia coli aconitase. J Biol Chem 266: 19328-19333.
30. Vasquez-Vivar J, Kalyanaraman B, Kennedy MC, (2000) Mitochondrial aconitase is a source of hydroxyl radical. An electron spin resonance investigation. J Biol Chem 275: 14064-14069.
31. Benov L, Sztejnberg L, Fridovich I, (1998) Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical. Free Radic Biol Med 25: 826-831.
32. Horak P, Crawford AR, Vadysirisack DD, Nash ZM, DeYoung MP, et al. (2010) Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis. Proc Natl Acad Sci U S A 107: 4675-4680.
33. Wang YC, Lee CM, Lee LC, Tung LC, Hsieh-Li HM, et al. (2011) Mitochondrial dysfunction and oxidative stress contribute to the pathogenesis of spinocerebellar ataxia type 12 (SCA12). J Biol Chem 286: 21742-21754.
34. Petrat F, Weisheit D, Lensen M, de Groot H, Sustmann R, et al. (2002) Selective determination of mitochondrial chelatable iron in viable cells with a new fluorescent sensor. Biochem J 362: 137-147.
35. Philpott CC, Klausner RD, Rouault TA, (1994) The bifunctional iron-responsive element binding protein/cytosolic aconitase: the role of active-site residues in ligand binding and regulation. Proc Natl Acad Sci U S A 91: 7321-7325.
36. Missirlis F, Holmberg S, Georgieva T, Dunkov BC, Rouault TA, et al. (2006) Characterization of mitochondrial ferritin in Drosophila. Proc Natl Acad Sci U S A 103: 5893-5898.
37. Geisler S, Holmstrom KM, Skujat D, Fiesel FC, Rothfuss OC, et al. (2010) PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol 12: 119-131.
38. Geisler S, Holmstrom KM, Treis A, Skujat D, Weber SS, et al. (2010) The PINK1/Parkin-mediated mitophagy is compromised by PD-associated mutations. Autophagy 6: 871-878.
39. Koh H, Chung J, (2012) PINK1 as a molecular checkpoint in the maintenance of mitochondrial function and integrity. Mol Cells 34: 7-13.
40. Yu W, Sun Y, Guo S, Lu B, (2011) The PINK1/Parkin pathway regulates mitochondrial dynamics and function in mammalian hippocampal and dopaminergic neurons. Hum Mol Genet 20: 3227-3240.
41. Imai Y, Lu B, (2012) Mitochondrial dynamics and mitophagy in Parkinson's disease: disordered cellular power plant becomes a big deal in a major movement disorder. Curr Opin Neurobiol 21: 935-941.
42. Twig G, Shirihai OS, (2011) The interplay between mitochondrial dynamics and mitophagy. Antioxid Redox Signal 14: 1939-1951.
43. Cantu D, Schaack J, Patel M, (2009) Oxidative inactivation of mitochondrial aconitase results in iron and H2O2-mediated neurotoxicity in rat primary mesencephalic cultures. PLoS ONE 4: e7095 doi:10.1371/journal.pone.0007095.
44. Liochev SI, Fridovich I, (1994) The role of O2.- in the production of HO.: in vitro and in vivo. Free Radic Biol Med 16: 29-33.
45. Sakurai K, Stoyanovsky DA, Fujimoto Y, Cederbaum AI, (2000) Mitochondrial permeability transition induced by 1-hydroxyethyl radical. Free Radic Biol Med 28: 273-280.
46. Srivastava S, Chan C, (2007) Hydrogen peroxide and hydroxyl radicals mediate palmitate-induced cytotoxicity to hepatoma cells: relation to mitochondrial permeability transition. Free Radic Res 41: 38-49.
47. Vercesi AE, Kowaltowski AJ, Grijalba MT, Meinicke AR, Castilho RF, (1997) The role of reactive oxygen species in mitochondrial permeability transition. Biosci Rep 17: 43-52.
48. Pitkanen S, Robinson BH, (1996) Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase. J Clin Invest 98: 345-351.
49. Turrens JF, (1997) Superoxide production by the mitochondrial respiratory chain. Biosci Rep 17: 3-8.
50. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, et al. (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3: 1301-1306.
51. Cannon JR, Tapias V, Na HM, Honick AS, Drolet RE, et al. (2009) A highly reproducible rotenone model of Parkinson's disease. Neurobiol Dis 34: 279-290.
52. Coulom H, Birman S, (2004) Chronic exposure to rotenone models sporadic Parkinson's disease in Drosophila melanogaster. J Neurosci 24: 10993-10998.
53. Dauer W, Przedborski S, (2003) Parkinson's disease: mechanisms and models. Neuron 39: 889-909.
54. Koh H, Kim H, Kim MJ, Park J, Lee HJ, et al. (2012) Silent information regulator 2 (Sir2) and Forkhead box O (FOXO) complement mitochondrial dysfunction and dopaminergic neuron loss in Drosophila PTEN-induced kinase 1 (PINK1) null mutant. J Biol Chem 287: 12750-12758.
55. Berman SB, Hastings TG, (1999) Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease. J Neurochem 73: 1127-1137.
56. Zhang F, Dryhurst G, (1994) Effects of L-cysteine on the oxidation chemistry of dopamine: new reaction pathways of potential relevance to idiopathic Parkinson's disease. J Med Chem 37: 1084-1098.
57. Zoccarato F, Toscano P, Alexandre A, (2005) Dopamine-derived dopaminochrome promotes H(2)O(2) release at mitochondrial complex I: stimulation by rotenone, control by Ca(2+), and relevance to Parkinson disease. J Biol Chem 280: 15587-15594.
58. Snyder AM, Connor JR, (2009) Iron, the substantia nigra and related neurological disorders. Biochim Biophys Acta 1790: 606-614.
59. Cha GH, Kim S, Park J, Lee E, Kim M, et al. (2005) Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila. Proc Natl Acad Sci U S A 102: 10345-10350.
60. Pesah Y, Pham T, Burgess H, Middlebrooks B, Verstreken P, et al. (2004) Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress. Development 131: 2183-2194.
61. Verstreken P, Ly CV, Venken KJ, Koh TW, Zhou Y, et al. (2005) Synaptic mitochondria are critical for mobilization of reserve pool vesicles at Drosophila neuromuscular junctions. Neuron 47: 365-378.
62. Dietzl G, Chen D, Schnorrer F, Su KC, Barinova Y, et al. (2007) A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila. Nature 448: 151-156.
63. Bischof J, Maeda RK, Hediger M, Karch F, Basler K, (2007) An optimized transgenesis system for Drosophila using germ-line-specific phiC31 integrases. Proc Natl Acad Sci U S A 104: 3312-3317.
64. Venken KJ, He Y, Hoskins RA, Bellen HJ, (2006) P[acman]: a BAC transgenic platform for targeted insertion of large DNA fragments in D. melanogaster. Science 314: 1747-1751.
65. Wu JS, Luo L, (2006) A protocol for dissecting Drosophila melanogaster brains for live imaging or immunostaining. Nat Protoc 1: 2110-2115.